학술논문
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study
Document Type
Article
Author
Source
In: Lung Cancer . (Lung Cancer, April 2024, 190)
Subject
Language
English
ISSN
18728332
01695002
01695002